Skip to main
BCPC

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Balchem is well-positioned to continue its strong financial performance, with modest revenue misses and earnings in line with estimates. The company's diversified segments, particularly the Human Nutrition and Health segment, are key drivers of growth. Potential geopolitical risks are mitigated by the company's strong presence in the United States and a solid balance sheet with a low net debt to leverage ratio. Additionally, management's focus on accretive M&A and paying down debt should contribute to future improvements in margins and further growth in the company's financial position.

Bears say

Balchem is projected to see revenue growth in the coming years due to potential increased demand for its specialty ingredients, particularly in the Human Nutrition and Health segment. However, operating expenses have also increased, which may impact profitability. Additionally, while the new research on choline's potential cognitive health benefits may drive demand for Balchem's products, competition in the market remains a concern.

Balchem (BCPC) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Buy based on their latest research and market trends.

According to 2 analysts, Balchem (BCPC) has a Buy consensus rating as of May 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.